Bolt Biotherapeutics (BOLT) Other Gross PP&E Adjustments (2020 - 2025)
Bolt Biotherapeutics' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$11.2 million for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 77.46% year-over-year to -$11.2 million; the TTM value through Sep 2025 reached -$11.2 million, down 77.46%, while the annual FY2024 figure was -$11.3 million, 34.81% down from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$11.2 million at Bolt Biotherapeutics, up from -$12.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $7.7 million in Q3 2021 and bottomed at -$16.0 million in Q4 2021.
- The 5-year median for Other Gross PP&E Adjustments is -$10.9 million (2023), against an average of -$8.1 million.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 360.44% in 2022 before it soared 33.04% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$16.0 million in 2021, then grew by 27.04% to -$11.7 million in 2022, then increased by 28.14% to -$8.4 million in 2023, then crashed by 34.81% to -$11.3 million in 2024, then rose by 0.79% to -$11.2 million in 2025.
- Per Business Quant, the three most recent readings for BOLT's Other Gross PP&E Adjustments are -$11.2 million (Q3 2025), -$12.0 million (Q2 2025), and -$12.6 million (Q1 2025).